194 related articles for article (PubMed ID: 24960127)
1. tLivin displays flexibility by promoting alternative cell death mechanisms.
Shiloach T; Berens C; Danke C; Waiskopf O; Perlman R; Ben-Yehuda D
PLoS One; 2014; 9(6):e101075. PubMed ID: 24960127
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin.
Nachmias B; Lazar I; Elmalech M; Abed-El-Rahaman I; Asshab Y; Mandelboim O; Perlman R; Ben-Yehuda D
Apoptosis; 2007 Jul; 12(7):1129-42. PubMed ID: 17294084
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity.
Abd-Elrahman I; Hershko K; Neuman T; Nachmias B; Perlman R; Ben-Yehuda D
Cancer Res; 2009 Jul; 69(13):5475-80. PubMed ID: 19549891
[TBL] [Abstract][Full Text] [Related]
4. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.
Lazar I; Yaacov B; Shiloach T; Eliahoo E; Kadouri L; Lotem M; Perlman R; Zakay-Rones Z; Panet A; Ben-Yehuda D
J Virol; 2010 Jan; 84(1):639-46. PubMed ID: 19864394
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the truncated form of Livin reveals a complex interaction with caspase-3.
Liu GH; Wang C; Ding ZY
Int J Oncol; 2013 Jun; 42(6):2037-45. PubMed ID: 23563149
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin.
Abd-Elrahman I; Deutsch V; Pick M; Kay S; Neuman T; Perlman R; Ben-Yehuda D
Cell Death Dis; 2013 Nov; 4(11):e937. PubMed ID: 24287698
[TBL] [Abstract][Full Text] [Related]
7. Livin, a novel inhibitor of apoptosis protein family member.
Kasof GM; Gomes BC
J Biol Chem; 2001 Feb; 276(5):3238-46. PubMed ID: 11024045
[TBL] [Abstract][Full Text] [Related]
8. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.
Abd-Elrahman I; Nassar T; Khairi N; Perlman R; Benita S; Ben Yehuda D
Oncogene; 2021 Jan; 40(2):334-344. PubMed ID: 33128043
[TBL] [Abstract][Full Text] [Related]
10. Challenge and promise: roles for Livin in progression and therapy of cancer.
Wang L; Zhang Q; Liu B; Han M; Shan B
Mol Cancer Ther; 2008 Dec; 7(12):3661-9. PubMed ID: 19074843
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of NK cytotoxicity by the IAP family member Livin.
Nachmias B; Mizrahi S; Elmalech M; Lazar I; Ashhab Y; Gazit R; Markel G; Ben-Yehuda D; Mandelboim O
Eur J Immunol; 2007 Dec; 37(12):3467-76. PubMed ID: 18034418
[TBL] [Abstract][Full Text] [Related]
12. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway.
Ma L; Huang Y; Song Z; Feng S; Tian X; Du W; Qiu X; Heese K; Wu M
Cell Death Differ; 2006 Dec; 13(12):2079-88. PubMed ID: 16729033
[TBL] [Abstract][Full Text] [Related]
13. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase.
Yan H; Brouha B; Liu T; Raj D; Biddle D; Lee R; Grossman D
J Dermatol Sci; 2006 Sep; 43(3):189-200. PubMed ID: 16806840
[TBL] [Abstract][Full Text] [Related]
15. Research progress on Livin protein: an inhibitor of apoptosis.
Yan B
Mol Cell Biochem; 2011 Nov; 357(1-2):39-45. PubMed ID: 21617971
[TBL] [Abstract][Full Text] [Related]
16. Isolation of peptides blocking the function of anti-apoptotic Livin protein.
Crnković-Mertens I; Bulkescher J; Mensger C; Hoppe-Seyler F; Hoppe-Seyler K
Cell Mol Life Sci; 2010 Jun; 67(11):1895-905. PubMed ID: 20177953
[TBL] [Abstract][Full Text] [Related]
17. Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells.
Crnković-Mertens I; Semzow J; Hoppe-Seyler F; Butz K
J Mol Med (Berl); 2006 Mar; 84(3):232-40. PubMed ID: 16437214
[TBL] [Abstract][Full Text] [Related]
18. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).
Vucic D; Deshayes K; Ackerly H; Pisabarro MT; Kadkhodayan S; Fairbrother WJ; Dixit VM
J Biol Chem; 2002 Apr; 277(14):12275-9. PubMed ID: 11801603
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.
Nachmias B; Ashhab Y; Bucholtz V; Drize O; Kadouri L; Lotem M; Peretz T; Mandelboim O; Ben-Yehuda D
Cancer Res; 2003 Oct; 63(19):6340-9. PubMed ID: 14559822
[TBL] [Abstract][Full Text] [Related]
20. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.
Sanna MG; da Silva Correia J; Ducrey O; Lee J; Nomoto K; Schrantz N; Deveraux QL; Ulevitch RJ
Mol Cell Biol; 2002 Mar; 22(6):1754-66. PubMed ID: 11865055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
